Frederique Lang

• Antibiotics
• HTA
• Quality of Life
• Antimicrobial Resistance (AMR)
• Health Technology Assessment…
• Value-Based Pricing

Capturing the Broader Value of Antibiotics

Read more

• Australia
• Canada
• Denmark
• England
• France
• Gene therapies
• Germany
• HTA
• Italy
• Spain
• Sweden
• Switzerland
• The Netherlands
• Cell and Gene Therapies
• Health Technology Assessment…

Are Recommendations for HTA of Gene Therapies Being Achieved?

Read more

• Economic Evaluation
• England
• Healthcare Delivery
• Healthcare Funding
• NHS
• NHS Expenditure
• Scotland
• UK
• Health Care Systems
• Health Data and Statistics
• Prevention

Reimagining Prevention for a Healthier, More Prosperous Society

Read more

• Antibiotics
• England
• NHS
• UK
• Value based pricing
• Antimicrobial Resistance (AMR)
• Drug Development/R&D
• Value-Based Pricing

Proposals for a Novel UK Antimicrobial Subscription Model: How Will Antibiotic Innovation be Scored?

Read more

• ABPI
• Antibiotics
• Antimicrobial Resistance (AMR)
• Value-Based Pricing

Incentivising New Antibiotics: Designing a Value-Based Delinked Pull Incentive Mechanism

Read more